INSIGHTS ON DRUG DEVELOPMENT
-
Drug Substance For Early Clinical Phase Initiation
Explore how proactive nitrosamine impurity risk assessment protects early clinical drug supply, minimizes development delays, and enables confident progression to first‑in‑human studies.
-
A Human-Relevant Model Of The Liver Sinusoid
This organ-on-a-chip model minimizes drug absorption while maintaining the essential architecture. Explore the specifications of this product engineered to model the human liver.
-
Creative Chromatography Solutions For Complex Small Molecules
Chromatographic modeling enables smarter purification. Discover how digital tools, fraction mapping, and expert execution can improve yield for the most challenging small-molecule separations.
-
Generate CHO-K1 GFP-Expressing Cells For Cell Line Development Workflow
Discover a high-efficiency workflow for generating GFP-expressing CHO-K1 clones using automated single-cell dispensing to achieve 93% isolation success and stable expression in under five weeks.
-
Quantifying Endotoxins Via Absorbance Or Fluorescence3/20/2026
Find out how endotoxin assays use Factor C activation to generate measurable absorbance or fluorescence signals, with guidance on selecting detection formats and implementing scalable workflows.
-
Seed Train Intensification Using High Cell Density Cryopreservation8/11/2025
Streamline your upstream bioprocessing with seed train intensification. Discover how high cell density cryopreservation reduces scale-up time, boosts consistency, and enhances manufacturing flexibility.
-
Improved Cell Viability For Multi-Day Cell-Based Assays7/24/2025
Ensure consistent cell health and assay reliability with controlled temperature and gas conditions. Discover how microplate readers with gas mixers enhance cell viability in live cell-based assays.
-
Functional Characterization Of 3D Assembled Neurospheres4/4/2025
Neural organoids and 3D spheroids offer advanced platforms for brain research and drug discovery. Discover how creating 3D neurospheres from iPSC-derived neurons and astrocytes aids in compound profiling and toxicity testing.
-
Column Selection For RPLC-UV Impurity Analysis7/17/2025
Explore the performance of four column chemistries for RPLC-UV impurity analysis of liraglutide and semaglutide, which offers practical guidance for method development in peptide-based therapeutics.
DRUG DEVELOPMENT SOLUTIONS
-
Easily analyze a diverse array of RNA species, from 50-9,000 bases, and achieve high-resolution data with a purity & integrity kit.
-
Analyzing GLP-1 receptor agonist (RA) drugs has become increasingly complex. Peptide structures, closely-related impurities, and rising demands for sensitivity, speed, and compliance are putting pressure on laboratories.
-
Explore how key biomarkers like Amyloid-beta, TAU, and α-Synuclein are transforming neurodegeneration research, with enhanced detection strategies that improve diagnostic accuracy.
-
Enhance therapeutic success by optimizing N-glycan profiles with titratable formulations tailored to meet your bioproduction needs.
-
Rapid, high-throughput IgG quantification assay. Available in 96 & 384-well microplate options.